Home » Stocks » TearLab

TearLab Corporation (TEAR)

Jul 9, 2020 - TEAR was delisted (reason: acquired)
Stock Price: $0.0579 USD -0.0011 (-1.86%)
Updated Jul 9, 2020 4:00 PM EDT

Stock Price Chart

Key Info

Market Cap 1.41M
Revenue (ttm) 22.06M
Net Income (ttm) -5.64M
Shares Out 24.41M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 9, 2020
Last Price $0.0579
Previous Close $0.0590
Change ($) -0.0011
Change (%) -1.86%
Day's Open -
Day's Range 0.0570 - 0.0579
Day's Volume 0
52-Week Range 0.0201 - 0.2150

More Stats

Market Cap 1.41M
Enterprise Value 32.70M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 24.41M
Float 732,617
EPS (basic) -0.44
EPS (diluted) -0.45
FCF / Share -0.12
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 625,019
Short Ratio 2.50
Short % of Float 85.31%
Beta 0.73
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 0.06
PB Ratio n/a
Revenue 22.06M
Operating Income 128,000
Net Income -5.64M
Free Cash Flow -1.53M
Net Cash -31.28M
Net Cash / Share -1.28
Gross Margin 66.84%
Operating Margin 0.58%
Profit Margin -25.60%
FCF Margin -6.91%
ROA 0.54%
ROE n/a
ROIC 1.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$4.00*
Low
4.00
Current: $0.0579
High
4.00
Target: 4.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue22.6625.0027.1228.0125.1619.7214.653.962.121.70
Revenue Growth-9.38%-7.82%-3.19%11.36%27.58%34.64%269.82%86.44%24.87%-
Gross Profit14.3015.5414.0115.7012.609.626.501.670.500.85
Operating Income0.282.46-11.79-15.98-31.51-25.00-17.77-12.03-8.06-6.94
Net Income-5.42-2.25-16.10-19.92-33.23-23.72-28.99-19.31-8.81-6.68
Shares Outstanding12.1810.625.794.653.373.363.082.551.771.41
Earnings Per Share-0.44-0.21-2.78-4.29-9.92-7.40-9.40-7.60-5.00-4.70
Operating Cash Flow-0.952.66-9.66-12.52-23.70-18.17-13.23-8.80-5.97-4.54
Capital Expenditures-0.41-0.46-0.99-1.43-3.39-2.42-2.91-0.57-0.16-0.06
Free Cash Flow-1.372.20-10.65-13.95-27.09-20.59-16.14-9.37-6.13-4.60
Cash & Equivalents7.118.477.2715.4713.8416.3437.7815.442.812.73
Total Debt37.2532.0128.2926.4524.86----1.67
Net Cash / Debt-30.14-23.54-21.02-10.98-11.0216.3437.7815.442.811.06
Assets14.2914.5114.3526.6328.3531.0349.9624.1410.5411.54
Liabilities40.3135.1832.9132.3532.346.408.599.305.023.66
Book Value-26.02-20.67-18.57-5.72-4.2424.3841.3714.845.527.88
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TearLab Corporation
Country United States
Employees 39
CEO Joseph S. Jensen

Stock Information

Ticker Symbol TEAR
Stock Exchange US OTC
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier OTCMKTS: TEAR
IPO Date December 8, 2004

Description

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. The company offers TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab Pen, a hand-held device that interfaces with the TearLab disposable; and TearLab Reader, a small desktop unit that allows for the docking of the TearLab Pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in Escondido, California.